Porous Se@SiO2 Nanospheres Attenuate Cisplatin-Induced Acute Kidney Injury Via Activation of Sirt1.

Xi Li,Qi Wang,Guoying Deng,Yinping Liu,Boxuan Wei,Xijian Liu,Wei Bao,Qiugen Wang,Sufang Wu
DOI: https://doi.org/10.1016/j.taap.2019.114704
IF: 4.46
2019-01-01
Toxicology and Applied Pharmacology
Abstract:Cisplatin (CDDP) is the most commonly used chemotherapeutic drug and has an irreplaceable role in cancer treatment. However, CDDP-induced acute kidney injury (AKI) greatly limits its use. Abundant evidence has confirmed that apoptosis contributes to AKI caused by CDDP administration. The nanoparticle form of selenium, also known as Se@SiO2 nanocomposites (NPs), has been proven to be a potential agent to prevent apoptotic cell death. In this article, we established acute kidney injury models in vivo via a single injection of CDDP and used human kidney 2 (HK-2) cells for experiments in vitro. We demonstrated that NPs can improve CDDP-induced renal dysfunction. In addition, therapy with NPs attenuated apoptosis in cells and kidney tissues treated with CDDP. In terms of mechanism, we discovered that Sirt1, a deacetylase with an important role in CDDP-induced acute kidney injury, was remarkedly increased after NPs pretreatment, and the anti-apoptotic effect of the NPs was markedly abrogated after the inhibition of Sirt1. The results linked the protective effect of NPs on nephrotoxicity with Sirt1, suggesting the potential clinical importance of nanomaterials in alleviating the side effects of chemotherapy.
What problem does this paper attempt to address?